Related Experiment Video
Updated: Mar 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 binds the mdmx mRNA and controls its translation
A-S Tournillon1, I López1, L Malbert-Colas1
1Equipe Labellisée la Ligue Contre le Cancer, Institut National de la Santé et de la Recherche Médicale UMR1162, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St Louis, Paris, France.
Abstract:
MDMX and MDM2 are two nonredundant essential regulators of p53 tumor suppressor activity. MDM2 controls p53 expression levels, whereas MDMX is predominantly a negative regulator of p53 trans-activity. The feedback loops between MDM2 and p53 are well studied and involve both negative and positive regulation on transcriptional, translational and post-translational levels but little is known on the regulatory pathways between p53 and MDMX. Here we show that overexpression of p53 suppresses mdmx mRNA translation in vitro and in cell-based assays. The core domain of p53 binds the 5' untranslated region (UTR) of the mdmx mRNA in a zinc-dependent manner that together with a trans-suppression domain located in p53 N-terminus controls MDMX synthesis. This interaction can be visualized in the nuclear and cytoplasmic compartment. Fusion of the mdmx 5'UTR to the ovalbumin open reading frame leads to suppression of ovalbumin synthesis. Interestingly, the transcription inactive p53 mutant R273H has a different RNA-binding profile compared with the wild-type p53 and differentiates the synthesis of MDMX isoforms. This study describes p53 as a trans-suppressor of the mdmx mRNA and adds a further level to the intricate feedback system that exist between p53 and its key regulatory factors and emphasizes the important role of mRNA translation control in regulating protein expression in the p53 pathway.
Insights
The tumor suppressor p53 directly inhibits the translation of MDMX mRNA, adding a new layer to the p53 regulatory feedback loop. This discovery highlights the crucial role of mRNA translation control in the p53 pathway.
Area of Science:
- Molecular Biology
- Cancer Biology
- Gene Regulation
Background:
- MDMX and MDM2 are key regulators of the p53 tumor suppressor.
- While MDM2-p53 interactions are well-studied, p53-MDMX regulatory pathways remain less understood.
- p53 controls gene expression via transcriptional and post-transcriptional mechanisms.
Purpose of the Study:
- To investigate the regulatory relationship between p53 and MDMX.
- To elucidate the mechanisms by which p53 influences MDMX protein levels.
- To explore the role of mRNA translation control in the p53 pathway.
Main Methods:
- In vitro and cell-based assays to study mRNA translation.
- RNA-binding assays using p53 core domain and 5' UTR of mdmx mRNA.
- Zinc-dependent binding studies.
- Reporter assays with fused mdmx 5'UTR and ovalbumin.
- Analysis of p53 mutant R273H RNA-binding profile.
Main Results:
- Overexpression of p53 suppresses mdmx mRNA translation.
- The p53 core domain binds the 5' UTR of mdmx mRNA in a zinc-dependent manner.
- p53's N-terminus trans-suppression domain further controls MDMX synthesis.
- Fusion of mdmx 5'UTR to ovalbumin suppresses ovalbumin synthesis.
- The p53 mutant R273H exhibits altered RNA-binding and differentiates MDMX isoform synthesis.
Conclusions:
- p53 acts as a trans-suppressor of mdmx mRNA, inhibiting its translation.
- This finding reveals a novel feedback mechanism in the p53 regulatory network.
- mRNA translation control is a critical component of p53 pathway regulation.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Master Transcription Regulators
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

